Posterior reversible encephalopathy syndrome in a child with cyclical vomiting and hypertension: a case report by Zakareya Gamie et al.
JOURNAL OF MEDICAL
CASE REPORTS
Posterior reversible encephalopathy syndrome in
a child with cyclical vomiting and hypertension:
a case report
Gamie et al.
Gamie et al. Journal of Medical Case Reports 2011, 5:137
http://www.jmedicalcasereports.com/content/5/1/137 (6 April 2011)
CASE REPORT Open Access
Posterior reversible encephalopathy syndrome in
a child with cyclical vomiting and hypertension:
a case report
Zakareya Gamie1*, Akheel Rizwan1, Frances G Balen2, Michael Clarke3 and Mohammed M Hassoon1
Abstract
Introduction: Posterior reversible encephalopathy syndrome is characterized by headache, nausea and vomiting,
seizures and visual disturbances. It has certain characteristic radiological features, which allow diagnosis in the
appropriate clinical setting and enable appropriate clinical therapy to be instituted.
Case presentation: A 10-year-old Caucasian girl who was hospitalized due to recurrent vomiting was diagnosed
as having posterior reversible encephalopathy syndrome after an initial diagnosis of cyclical vomiting and
hypertension was made.
Conclusion: Posterior reversible encephalopathy syndrome is a rare disorder in children. Early recognition of
characteristic radiological features is key to the diagnosis as clinical symptoms may be non-specific or mimic other
neurological illnesses. To the best of our knowledge this is the first case to report an association between posterior
reversible encephalopathy syndrome, cyclical vomiting and hypertension. Furthermore, in this case, the resolution
of the abnormalities found on magnetic resonance imaging over time did not appear to equate with clinical
recovery.
Introduction
Posterior reversible encephalopathy syndrome (PRES) is
characterized by headache, nausea, vomiting, seizures
and visual disturbances [1]. PRES is commonly asso-
ciated with a sudden increase in blood pressure (BP) [1].
The MRI findings have been well characterized and
include vasogenic edema in the white matter of the pos-
terior regions of the cerebral hemispheres, particularly
in the parieto-occipital regions [2]. PRES is more com-
monly reported in adults. The cause of PRES is thought
to be multi-factorial, and it may develop in patients who
have hypertension, renal disease, or who are immuno-
suppressed [1,3]. PRES is usually reversible and prompt
recognition is important [1]. In the pediatric population,
PRES has been associated with chronic renal disease [4],
the administration of chemotherapeutic agents [5], adre-
nocortical disease and Cushing’s syndrome [6].
We present the case of a 10-year-old girl found to
have PRES in association with cyclical vomiting and
hypertension.
Case presentation
A 10-year-old Caucasian girl presented to our department
with ongoing symptoms of vomiting, non-specific abdom-
inal pain and hypertension. She had been admitted about
15 times over a three year period with episodic attacks of
frequent and severe vomiting lasting for a few days. Dur-
ing some of her admissions she demonstrated neurological
and autonomic signs and symptoms such as confusion,
disorientation, occipital headache, visual impairment, star-
ing look, lack of response, head and eye turning to one
side with nystagmus, non-reactive pupils, left arm and leg
stiffening, and fluctuating and raised BP.
Investigations included abdominal and chest radio-
graphs, and abdominal and renal ultrasonography,
which all gave negative results. Gastroscopy and barium
meal studies did not reveal any abnormalities, but a
urease breath test revealed Helicobacter pylori, which
was treated with standard triple therapy. A cranial
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computed tomography (CT) scan did not reveal any
abnormalities; however, a magnetic resnonace imaging
(MRI) scan (Philips Intera 1.5T) demonstrated patchy
areas of mainly subcortical high signal without mass
effect, contrast enhancement or associated diffusion
restriction. These abnormalities were bilateral but asym-
metrical, affecting the right cerebral hemisphere more
than the left side. The high signal lesions were mainly
located in the posterior brain, particularly the parieto-
occipital lobes. No abnormality was seen in the posterior
fossa or the basal ganglia. The radiological features were
consistent with a diagnosis of PRES (Figures 1 and 2).
An abdominal MRI was unremarkable.
Electroencephalographic (EEG) studies initially demon-
strated marked right hemisphere slow wave disturbances;
however, repeat studies showed no definite epileptiform
abnormality, with slow and asymmetrical, frequent theta
and slow activity consistent with non-specific focal
organic disturbance of cerebral activity. The results of
24-hour BP monitoring (38 readings in total) revealed 10
systolic readings >118 mmHg (95th centile). Electrocar-
diographic (ECG) studies were also unremarkable. Mid-
night and morning cortisol levels were within the normal
ranges. Other investigations such as urinary catechola-
mines, serum amylase, lactate, ammonia, cholesterol,
chloride, and bicarbonate were all within normal ranges.
Other investigations with normal outcomes included
tests for urine porphyrin, anti-mitochondrial antibodies
(AMA), anti-nuclear antibodies (ANA), double-stranded
DNA (dsDNA), anti-smooth muscle antibodies (ASA),
liver-kidney microsomal (LKM) antibodies, gastric parie-
tal cell antibodies, carnitine and acylcarnitines, and a coe-
liac screen. A screen for orotic acid was also normal. No
abnormality was detected in the urinary organic acids,
but there was a slight increase in the urine amino acids.
Investigations for porphyria were also normal.
Our patient was treated with the antiemetics ondanse-
tron and cyclizine, and a trial of lorazepam was also
given to try and abort the vomiting cycle. Electrolyte
abnormalities were treated using intravenous fluids. At
five months after her initial MRI, a repeat scan was per-
formed and all the abnormal features had resolved. Her
seizure-like symptoms settled and the vomiting episodes
became shorter and less frequent. She continued to have
ongoing symptoms of acute episodes of vomiting asso-
ciated with hypertension for a further three months.
Treatment included ondansetron, atenolol and clarithro-
mycin. Her symptoms eventually settled and she has
remained symptom free for a period of about 6 months.
Discussion
PRES is a disorder of cerebrovascular autoregulation
with multiple underlying etiologies and it is commonly
Figure 1 Coronal fluid attenuation inversion recovery (FLAIR)
MRI through the posterior brain showing bilateral patchy
areas of high signal within the subcortical white matter of
right occipital lobe and left parietal lobe.
Figure 2 T2 sagittal MRI through a right paracentral position
showing multiple subcortical white matter lesions in the right
temporal lobe anteriorly, and the right occipital lobe
posteriorly.
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associated with increases in BP [1]. In the pediatric
population, PRES has been associated with chronic renal
disease [4], the administration of chemotherapeutic
agents [5], adrenocortical disease and Cushing’s syn-
drome [6]. It is thought that the sudden elevation in
blood pressure leads to disruption of the autoregulatory
mechanisms in the central nervous system, vasodilata-
tion and vasoconstriction resulting in a breakdown of
the blood-brain barrier [5]. However, it is documented
in some cases, particularly in the pediatric population,
that BP may be only minimally elevated or fluctuant
during the development of PRES [7].
The diagnosis of PRES can be made via CT, but MRI
is a more sensitive imaging modality. The radiological
appearance of PRES does not seem to be influenced by
the predisposing factor [2]. The most common abnorm-
alities on CT and/or MRI scans are focal regions of
vasogenic edema involving the white matter in the pos-
terior cerebral hemispheres, often asymmetrically and
most commonly involving the parieto-occipital lobes
bilaterally, often in a watershed-type distribution. The
medial occipital lobe structures are spared, which distin-
guishes PRES from bilateral posterior cerebral artery
infarcts. The posterior predilection of this condition has
been ascribed to the fact that these vascular territories
are sparsely innervated with sympathetic nerves [7].
Lesions that are high signal on T2-weighted fluid atte-
nuated inversion recovery (FLAIR) sequences can also
be seen in the frontal lobes, the temporal-occipital lobe
and the basal ganglia and cerebellum. Patchy grey mat-
ter involvement is also recognized. MRI diffusion-
weighted imaging (DWI) demonstrates that the areas of
abnormality represent vasogenic edema, which is usually
completely reversible once therapy is instituted [7].
Rarely, contrast enhancement can occur, presumed to
reflect disruption of the blood-brain barrier. In most
patients who have repeat MRI scans after correction of
hypertension, there is improvement or resolution of
radiological abnormalities, although hemorrhages (seen
in approximately 15% of cases) can cause permanent
structural damage [7].
Manifestations of PRES in the adult population
include seizures, visual disturbances and headache [1].
In children, studies have also found that seizures, head-
ache and altered mental status can be the most common
clinical features [5]. The other symptoms being nausea
and vomiting, and blurring of vision [5]. Studies have
also revealed an altered autonomic response in patients
with cyclical vomiting [8,9] and there can be a heigh-
tened sympathetic cardiovascular tone [10] and symp-
toms such as pallor, flushing, lethargy and fever [11].
The stress response may induce episodes of cyclical
vomiting with infectious, physical or psychological stres-
sors potentially triggering an episode [12]. It has been
reported that an increased level of adrenocorticotropic
hormone (ACTH) and cortisol can be associated with
lethargy and hypertension before the onset of vomiting
[12], and it has been hypothesized that corticotropin-
releasing factor (CRF) may be a brain-gut mediator that
directly connects stress and vomiting [13].
In our patient, cyclical vomiting and hypertension
coexisted and were associated with PRES. Our patient
was extensively investigated for endocrine, renal, gastro-
intestinal, neurological, cardiac and metabolic causes
with no conclusive pathology. Macrolides and ondanse-
tron were effectively used to prevent episodes of vomit-
ing or to decrease their frequency, and this has been
previously been reported in the literature [14,15].
A recent in vitro study has also highlighted the effective-
ness of clarithromycin as a prokinetic agent [16], and in
our patient it was better tolerated than erythromycin.
However, more studies are required to compare the
effectiveness of the two agents in patients with cyclical
vomiting. Other modes of therapy include the use of tri-
cyclic antidepressants, newer antiepileptic agents such as
leveteracetam and topiramate, and the use of antimi-
graine medications such as sumitriptan [15]. Supportive
care involves use of intravenous fluids, sedatives, analge-
sia and the avoidance of potential triggering factors.
Conclusion
PRES is a rare disorder in children. Early recognition of
characteristic radiological features is key to the diagnosis
as clinical symptoms may be non-specific or mimic
other neurological illnesses. To the best of our knowl-
edge this is the first case to report an association
between PRES, cyclical vomiting and hypertension.
Furthermore, in this case, the resolution of the abnorm-
alities found on MRI over time did not appear to equate
with clinical recovery.
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